Physician profile
Smeet Patel
NPI 1740668300
$5,184.95
in general payments reported to CMS, 2019-2025
20 companies · $975 in 2025
The $975 reported for 2025 was more than what 85% of Diagnostic Radiology providers received nationally (typical 2025 total: $112).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $591 · 2021: $2,869 · 2022: $375 · 2023: $71.55 · 2024: $304 · 2025: $975.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,350.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,349.83 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Penumbra, INC. | $2,368.72 | 2021-2025 | Ruby Coil, Indigo System, Penumbra System |
| Argon Medical Devices, INC. | $676.13 | 2021-2025 | Clot Management, Clot Management |
| Bard Peripheral Vascular, INC. | $371.63 | 2020-2021 | |
| Medtronic Vascular, INC. | $270.93 | 2020 | |
| Cook Medical LLC | $242.15 | 2020-2021 | |
| Terumo Medical Corporation | $196.96 | 2023-2025 | Azur Cx Detachable, Glidewire, Hydropearl |
| Shockwave Medical, INC | $186.76 | 2025 | |
| Inari Medical, INC. | $140.53 | 2020 | |
| Siemens Medical Solutions USA, INC. | $130.95 | 2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $118.24 | 2025 | Gattex |
| Boston Scientific Corporation | $93.29 | 2020-2022 | |
| W. L. Gore & Associates, INC. | $84.92 | 2025 | Gore Tag Thoracic Branch Endoprosthesis |
| Abbott Laboratories | $71.30 | 2023-2024 | Freestyle Libre 3, Freestyle Libre 2 |
| Philips North America LLC | $67.07 | 2020-2021 | |
| Imperative Care, INC | $44.83 | 2025 | Symphony Catheter |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $39.91 | 2025 | Zepbound, Mounjaro, Kisunla |
| Janssen Pharmaceuticals, INC | $25.03 | 2024 | Invega |
| Medtronic, INC. | $23.89 | 2022 | |
| Allergan, INC. | $16.02 | 2020 | |
| Abbvie INC. | $15.69 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Smeet Patel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.